|
|
Volumn 146, Issue 6, 2007, Pages 416-424
|
|
Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: A randomized trial
b
c
d
c
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
ANTIANDROGEN;
CALCIUM CARBONATE;
GONADORELIN AGONIST;
PLACEBO;
VITAMIN D;
BIOLOGICAL MARKER;
BONE DENSITY CONSERVATION AGENT;
ABDOMINAL PAIN;
AGED;
ANDROGEN DEPRIVATION THERAPY;
ARTHRALGIA;
ARTICLE;
BASAL CELL CARCINOMA;
BONE DENSITY;
BONE DISEASE;
BONE MASS;
BONE TURNOVER;
CALCIUM INTAKE;
CANCER HORMONE THERAPY;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COLON POLYP;
CONFIDENCE INTERVAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CROSSOVER PROCEDURE;
DISEASE MARKER;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG FATALITY;
ESOPHAGUS STRICTURE;
FEMUR NECK;
FRACTURE;
GASTRITIS;
GASTROESOPHAGEAL REFLUX;
HEMORRHOID;
HIP;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
MICTURITION;
MYALGIA;
NAUSEA;
OSTEOLYSIS;
OSTEOPOROSIS;
PARALLEL DESIGN;
PRIORITY JOURNAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
RIGIDITY;
SIDE EFFECT;
SKIN INFECTION;
SPINE;
STATISTICAL SIGNIFICANCE;
STOMACH PAIN;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
VERTEBRAL CANAL STENOSIS;
VITAMIN SUPPLEMENTATION;
ADULT;
CHEMICALLY INDUCED DISORDER;
METABOLISM;
MIDDLE AGED;
PROSTATE TUMOR;
RISK FACTOR;
ADULT;
AGED;
AGED, 80 AND OVER;
ALENDRONATE;
ANDROGEN ANTAGONISTS;
BIOLOGICAL MARKERS;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
BONE RESORPTION;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
HIP;
HUMANS;
MALE;
MIDDLE AGED;
PROSTATIC NEOPLASMS;
RISK FACTORS;
SPINE;
|
|
EID: 33947732766
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-146-6-200703200-00006 Document Type: Article |
|
Times cited : (265)
|
|
References (30)
|
